WO2002051855A3 - Motilide compounds - Google Patents
Motilide compounds Download PDFInfo
- Publication number
- WO2002051855A3 WO2002051855A3 PCT/US2001/043963 US0143963W WO02051855A3 WO 2002051855 A3 WO2002051855 A3 WO 2002051855A3 US 0143963 W US0143963 W US 0143963W WO 02051855 A3 WO02051855 A3 WO 02051855A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- motilide
- motilide compounds
- formulas
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01995209A EP1337540A2 (en) | 2000-12-01 | 2001-11-21 | Motilide compounds |
AU2002225724A AU2002225724A1 (en) | 2000-12-01 | 2001-11-21 | Motilide compounds |
JP2002552948A JP2004522726A (en) | 2000-12-01 | 2001-11-21 | Motilide compounds |
CA002429709A CA2429709A1 (en) | 2000-12-01 | 2001-11-21 | Motilide compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25064000P | 2000-12-01 | 2000-12-01 | |
US60/250,640 | 2000-12-01 | ||
US26936201P | 2001-02-15 | 2001-02-15 | |
US60/269,362 | 2001-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002051855A2 WO2002051855A2 (en) | 2002-07-04 |
WO2002051855A3 true WO2002051855A3 (en) | 2002-10-31 |
Family
ID=26941026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/043963 WO2002051855A2 (en) | 2000-12-01 | 2001-11-21 | Motilide compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1337540A2 (en) |
JP (1) | JP2004522726A (en) |
AU (1) | AU2002225724A1 (en) |
CA (1) | CA2429709A1 (en) |
WO (1) | WO2002051855A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003273254B2 (en) * | 2002-08-29 | 2008-10-30 | Bristol-Myers Squibb Company | Motilide compounds |
AR043050A1 (en) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME |
US7407941B2 (en) * | 2003-08-26 | 2008-08-05 | Pfizer, Inc. | N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
JP4737495B2 (en) * | 2004-01-14 | 2011-08-03 | 塩野義製薬株式会社 | Erythromycin derivative |
US8202843B2 (en) * | 2004-02-27 | 2012-06-19 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
CN108101948A (en) * | 2004-02-27 | 2018-06-01 | 瑞伯-X医药品有限公司 | Macrocyclic compound and its making and use method |
WO2007025089A2 (en) | 2005-08-24 | 2007-03-01 | Rib-X Pharmaceutical, Inc. | Triazole compounds and methods of making and using the same |
ES2638427T3 (en) * | 2005-08-24 | 2017-10-20 | Melinta Therapeutics, Inc. | Triazole compounds and preparation and use procedures |
AU2006300215B2 (en) * | 2005-10-14 | 2012-06-21 | Aphoenix, Inc. | Novel dihydropseudoerythromycin derivatives |
CA2662897C (en) | 2006-09-11 | 2017-11-07 | Tranzyme Pharma, Inc. | Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
WO2008106204A1 (en) * | 2007-02-28 | 2008-09-04 | Rib-X-Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018134A1 (en) * | 1991-04-09 | 1992-10-29 | Abbott Laboratories | Macrocyclic lactam prokinetic agents |
JPH08231580A (en) * | 1994-12-27 | 1996-09-10 | Chugai Pharmaceut Co Ltd | Erythromycin derivative |
WO2000062783A2 (en) * | 1999-04-16 | 2000-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
-
2001
- 2001-11-21 AU AU2002225724A patent/AU2002225724A1/en not_active Abandoned
- 2001-11-21 EP EP01995209A patent/EP1337540A2/en not_active Withdrawn
- 2001-11-21 JP JP2002552948A patent/JP2004522726A/en not_active Withdrawn
- 2001-11-21 CA CA002429709A patent/CA2429709A1/en not_active Abandoned
- 2001-11-21 WO PCT/US2001/043963 patent/WO2002051855A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018134A1 (en) * | 1991-04-09 | 1992-10-29 | Abbott Laboratories | Macrocyclic lactam prokinetic agents |
JPH08231580A (en) * | 1994-12-27 | 1996-09-10 | Chugai Pharmaceut Co Ltd | Erythromycin derivative |
WO2000062783A2 (en) * | 1999-04-16 | 2000-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
Non-Patent Citations (2)
Title |
---|
FAGHIH R ET AL: "Preparation of 9-deoxo-4-deoxy-6,9-epoxyerythromycin lactams motilactides: potent and orally active prokinetic agents", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 8, no. 7, 7 April 1998 (1998-04-07), pages 805 - 810, XP004136969, ISSN: 0960-894X * |
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 01 31 January 1997 (1997-01-31) * |
Also Published As
Publication number | Publication date |
---|---|
AU2002225724A1 (en) | 2002-07-08 |
WO2002051855A2 (en) | 2002-07-04 |
CA2429709A1 (en) | 2002-07-04 |
JP2004522726A (en) | 2004-07-29 |
EP1337540A2 (en) | 2003-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3276802A (en) | Background of the invention | |
MXPA03009558A (en) | Novel compounds. | |
WO2002040495A3 (en) | Improved sucralose composition and process for the crystallization thereof | |
WO2001098236A3 (en) | 7-phenyl-substituted tetracycline compounds | |
ZA200109073B (en) | Compositions for treatment of disorders of the oesophagus. | |
AP2004003002A0 (en) | azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease. | |
MXPA03008547A (en) | Stabilization of aroma-providing components. | |
EP1426370A4 (en) | Propanolamine derivative having 1,4 benzodioxane ring | |
MXPA03009698A (en) | Novel composition. | |
DK1455794T3 (en) | CIC-2 channel opener for the treatment of gastric or intestinal ulcer | |
WO2002051855A3 (en) | Motilide compounds | |
WO2005060693A3 (en) | 9-desoxoerythromycin compounds as prokinetic agents | |
NO20041736L (en) | Process for the preparation of friction-reducing polymer suspensions. | |
WO2004019879A8 (en) | Motilide compounds | |
MXPA03000914A (en) | Synthesis of (r. | |
NO20026219L (en) | Compounds for the treatment of impaired fundic relaxation | |
EP1461030A4 (en) | Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma | |
MXPA03007928A (en) | Improved process for producing emulsified salad dressings background of the invention. | |
MXPA02006102A (en) | Process for the preparation of bromodifluoroacetic compounds. | |
WO2002047604A3 (en) | Novel use of chalcone class compounds for inhibiting tumoral mass vascularization | |
MXPA03008946A (en) | Methods of synthesizing phenol-containing compounds. | |
AU2002364711A8 (en) | Substituted 5-hydroxy-indole compounds for the treatment of glaucoma | |
DZ3356A1 (en) | Novel polymorph v of torasemide. | |
ITGE20020050A0 (en) | PROCEDURE FOR THE TREATMENT OF YARNS BY NEEDLETING. | |
MXPA03001472A (en) | Compounds for the treatment of addictive disorders. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2429709 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002552948 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001995209 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001995209 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001995209 Country of ref document: EP |